Getting Cardiovascular: Baseline Risk and Hypertension Treatment and Dual Antiplatelet Therapy in Coronary Stents
This Week: Baseline cardiovascular risk calculators and hypertension treatment, and dual antiplatelet treatment after coronary stenting
This week, Fahad and Amol want you to understand that:
1. A cardiovascular risk calculator can predict the degree of treatment benefit that patients may derive from blood pressure treatment.
2. There is limited evidence to recommend continuing dual antiplatelet therapy beyond 12 months after coronary stenting.
Continuing Medical Education
Internists can receive 0.5 hours of Continuing Medical Education credit for each podcast they listen to through the Canadian Society of Internal Medicine (MOC Category 1) and the American Medical Association (PRA Category 1). To receive CME credit for listening to this podcast, please click here to fill out our Evaluation and Impact Assessment Form.
The Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014 Aug 16;384(9943):591-8. (PubMed).
Risk and decision making in patients with hypertension. Lancet 2014 Aug 16;384(9943):562-4.(PubMed).
Please help us evaluate The Rounds Table by filling out our survey.